Newron Pharmaceuticals S.p.A. is a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system. Xadago® (safinamide) has received marketing authorization for the treatment of Parkinson’s disease in the European Union, Switzerland and the USA, and is commercialized by Newron’s Partner Zambon. US WorldMeds holds the commercialization rights in the USA. Meiji Seika, in collaboration with Eisai, has the rights to develop and commercialize the compound in Japan and other key Asian territories. In addition to Xadago® for Parkinson’s disease, Newron has a strong pipeline of promising treatments for rare disease patients at various stages of clinical development, including sarizotan for patients with Rett syndrome and ralfinamide for patients with specific rare pain indications. Newron is also developing Evenamide as the potential first add-on therapy for the treatment of patients with positive symptoms of schizophrenia. Founded in 1999, Newron is headquartered in Bresso, near Milan, Italy, with a subsidiary in Morristown, NJ, USA. The Company is listed on the SIX Swiss Exchange, trading symbol NWRN.

Zambon SpA is engaged in manufacturing pharmaceutical products. It offers anauran, anaurette, asacol, codex, fluimucil, and giason. The company is headquartered in Bresso, Italy.

Shanghai Pharmaceuticals Holding Co., Ltd. engages in the research and development, manufacture, distribution, and retail of pharmaceutical products. The company was founded on January 18, 1994 and is headquartered in Shanghai, China.

Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd., established on 2001-08-31, Business scope includes pharmaceuticals,Research and Development of Disinfectants,production and sales(Operate according to the scope listed in the license,involved in the law,Do not operate if prohibited by laws and regulations,Operating with a license involved in operating with a license).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Medichem SA is a Spanish company located in Sant Joan Despi with domestic subsidiaries. The firm manufactures and supplies pharmaceutical ingredients. It was founded in 1972. José Luis Rodríguez has been the CEO since 1996.

RK Pharma, Inc. is a company headquartered in Pearl River, NY, that develops, manufactures and commercializes generic pharmaceutical products. It was founded by Ravishanker Kovi. George R. Thomas is currently the CEO of the firm.\nThe company says this about itself: RK Pharma Inc is a privately held US based company. We focus on the development, manufacturing, and sale of high quality and affordable generic pharmaceutical products worldwide. RK Pharma Inc. has a unique position in integrated development, manufacturing and Regulatory capabilities, with a focus on products with formulation challenges and first generic opportunities.

Foshan Hongtai Drug Research and Development Co., Ltd., established on 2016-07-20, Business scope includes services:pharmaceutical research,Health food science and technology research and food science and technology research and its technology transfer,technical consulting;Sales:Plant extracts,Class I medical device;Engage in the operation of Chinese herbal medicines with valid approval certificates.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Shanghai Kesheng Pharmaceutical Research and Development Co., Ltd., established on 2005-04-08, Business scope includes biological,Research and development of pharmaceutical products and technology transfer,Sales of pharmaceutical intermediates,Engaged in the import and export of goods and technology. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Tianjin Hankang Pharmaceutical Biotechnology Co., Ltd. is a high-tech enterprise with independent intellectual property rights and specialized in R&D, production and sales of pharmaceuticals. In 2009, he was awarded the title of “Tianjin Enterprise Technology Center”. In 2013, he was included in the list of small giant growth companies that the mayor focused on. In 2014, Hankang R&D Center was named “Tianjin Key Laboratory of Enterprises”. 　　Hankang is mainly engaged in the research of new chemical drugs, and the technical sources are all independent research and development. The company has a professional research team, technicians are all undergraduate or above, and at the same time employ many well-known domestic and foreign experts as technical consultants, scientific research results are remarkable. At present, more than 180 products have been successfully developed, more than 40 new drug certificates, more than 90 clinical approvals for new drugs, and more than 40 production approvals. He applied for more than 140 invention patents and obtained more than 60 invention patent certificates. He was awarded Tianjin Tianjin Invention Patent Pilot Enterprise twice.

Jiangsu Yangtze River Pharmaceutical Group Co., Ltd. manufactures and distributes pharmaceutical products. It is a large cross-regional pharmaceutical group that features industry-university-institute cooperation and integrates scientific research, industrial production and sale. The company was founded in 1971 and is headquartered in Taizhou, China.

Hefei Meilikang Pharmaceutical Technology Co., Ltd., established on 2011-09-02, Business scope includes Chinese patent medicine,Western medicine,Health products,R&D of cosmetics,technical consulting,Services and Transfers;Medical Device II,Three types of sales;Medical equipment rental;stationery,Daily necessities,Health Supplies,Chemical raw materials(Does not contain dangerous goods),Sales of topical disinfectants;General Electronics,Instrumentation equipment and accessories,Sales of computer printers and accessories,repair,Serve;Electronic computer and software development,network integration,Promotion of machinery and equipment,consult,Serve;Realtor;interior and exterior decoration;Self-operated and agent import and export business of various commodities and technologies(Products and technologies restricted or prohibited by the state are excluded).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Biophore is a developer and manufacturer of pharmaceutical products for the generic industry.

Zenkom is a pharmaceutical group integrating drug research and development, manufacturing, and product sales. They provide reassuring medicines that are both safe and effective for the entire society. Their products involve oral solid preparations, oral liquid preparations, small-volume injections, and powder injections.

Shenzhen Zhenqiang Biotechnology Co., Ltd., established on 2012-05-10, Business scope includes general business items:Biological product,chemical reagent,Chemical Products,electronic product,Technical development and purchase and sale of laboratory instruments(Does not contain flammable, explosive, highly toxic and other dangerous chemicals,restricted items);Domestic Trade;Import and export of goods and technology;Acting drug declaration and registration;Medical Technology Development,consult,transfer.Face mask,protective suit,Forehead thermometer,thermometer,Gloves,goggles,ear thermometer,R&D and sales of Class II medical devices(It can only be operated after obtaining the record for the operation of second-class medical devices);Operating e-commerce;Scientific Research and Technical Services.,The licensing program is:books,newspaper,periodicals,Retail and Wholesale of Electronic Publications.

Aurobindo Pharma Ltd. engages in the manufacturing of generic pharmaceuticals and active pharmaceutical ingredients. Its portfolio includes antibiotics, anti-retrovirals, cardiovascular, central nervous system, gastroenterological, anti-allergies, and anti-diabetics. The company was founded by Penaka Venkata Ramprasad Reddy and Kambam Nithyananda Reddy on December 26, 1986 and is headquartered in Hyderabad, India.

Jiangsu Hengsheng Pharmaceutical Co., Ltd., established on 2002-09-29, The scope of business includes the production of veterinary drugs(Only operate according to the items listed in the license),Production of p-methylsulfonyl phenylserine ethyl ester,Production of pharmaceutical intermediates(Androstrol Acid,androstanthiocarboxylic acid,androstyl thiocarboxylate propionate,Benzylhexylamine Dihydroxyacetophenone Fumarate,Hexylamine bishydroxyacetophenone,indole ethylene sulfonamide,Pyrrolidinecarbonitrile,Aminopyrazinamide,Acetylneuraminic acid methyl ester,aminoanhydroneuraminic acid,Chloroquinoline benzyl alcohol,Chloroquinoline benzyl alcohol mesylate,Chloroquinoline cyproacetic acid,Dihydroxyazetidinone,aldehyde azetidinone,fluorobenzyl alcohol azetidinone),Chemical raw materials(Excluding hazardous chemicals)purchase and sale,Self-operated and agent import and export business of various commodities or goods(Except for goods that the state restricts the company to operate or prohibits import and export),API(naproxen,zanamivir,montelukast sodium,Rosiglitazone,Ezetimibe,fluticasone propionate,salmeterol hydroxynaphthoate,naratriptan,salbutamol sulfate,Vildagliptin,sitagliptin,L-Alanine)R & D pilot test,medicine,biology,Technology development in the field of chemistry,technical consulting,Technical Services,technology transfer.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) General project:Chemical product production(No licensed chemical products);Chemical product sales(No licensed chemical products)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Enaltec Labs Pvt Ltd., a subsidiary of La Renon Healthcare Pvt Ltd., is an Indian company located in Mumbai. The firm manufactures and supplies pharmaceutical products. It was founded in 2006. Anand Prafulchandra Shah is the current CEO of the firm. La Renon Healthcare Pvt Ltd. acquired Enaltec Labs Pvt Ltd. on January 20, 2022.

Zhejiang Huahai Pharmaceutical Co. Ltd. engages in the manufacture and sale of pharmaceutical products. It also integrates and intermediates formulations such as Active Pharmaceutical Ingredients. Its products include Irbesartan and Hydrochlorothiazide Tablet, Paroxetine Hydrochloride Tablet and Irbesartan Tablet. The company was founded in 1989 and is headquartered in Zhejiang, China.

Zhejiang Huahai Pharmaceutical Co., Ltd. Shanghai Branch, established on 2004-04-22, The scope of business includes import and export of goods and technology. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Chengdu Weiheng Pharmaceutical Technology Co., Ltd., established on 2015-04-17, Business scope includes pharmaceutical and medical device technology research and development,technology transfer,Technical Services,food,cosmetic,Daily chemical products,disinfection products,R&D and sales of feed additives.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).